Search Videos and More

Showing 1 - 11 of 11 results


ESMO Congress 2022 Preview Document

ESMO Congress 2022 Preview

Preview Studies and Symposia Featuring Dana-Farber Faculty
Marla Lipsyc-Sharf, MD on ctDNA in Breast Cancer Video

Marla Lipsyc-Sharf, MD on ctDNA in Breast Cancer

Using ctDNA found with liquid biopsy to understand recurrence risk in hormone receptor-positive breast cancer: Dana-Farber's Marla Lipsyc-Sharf MD, details research presented at #ASCO22 and published in the Journal of Clinical Oncology.
Improved Progression-Free Survival in Patients with Multiple Myeloma Following Three-Drug Therapy with Autologous Stem Cell Transplant News

Improved Progression-Free Survival in Patients with Multiple Myeloma Following Three-Drug Therapy with Autologous Stem Cell Transplant

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option.
Targeted Drug Achieves 43% Response Rate in KRAS-Mutated Lung Cancer News

Targeted Drug Achieves 43% Response Rate in KRAS-Mutated Lung Cancer

Nearly 43% of patients with non-small cell lung cancer (NSCLC) whose lung cancers harbored a specific KRAS mutation responded to the experimental drug adagrasib, and the targeted agent also showed activity against lesions in the brain that metastasized from the lung tumors, according to results of a study led by Dana-Farber Cancer Institute investigators.
Race, Ethnicity, and Poverty Linked to Worse Outcomes in Children Treated for High-Risk Neuroblastoma News

Race, Ethnicity, and Poverty Linked to Worse Outcomes in Children Treated for High-Risk Neuroblastoma

Children with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, according to a study led by investigators from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Transatlantic Exchanges in Immuno-Oncology Video

Transatlantic Exchanges in Immuno-Oncology

Join our transatlantic panel of experts for an interactive, full-day virtual conference to be up to date with all the most exciting discoveries in immuno-oncology!
2022 SGO Highlights Symposium

2022 SGO Highlights

DFCI Faculty share highlights from the Society of Gynecologic Oncology Annual Meeting on Women's Cancers held on March 18-21, 2022, in Phoenix, AZ and online.
2022 GU ASCO Bladder Cancer Highlights Video

2022 GU ASCO Bladder Cancer Highlights

Bladder Cancer Highlights featuring Guru Sonpavde, MD
2022 GU ASCO Prostate Cancer Highlights Video

2022 GU ASCO Prostate Cancer Highlights

Prostate Cancer Highlights featuring Jacob Berchuck, MD and Chris Sweeney, MBBS
2022 GU ASCO Kidney Cancer Highlights Video

2022 GU ASCO Kidney Cancer Highlights

Kidney Cancer Highlights featuring Vincent Xu, MD and Toni Choueiri, MD
2022 ASCO GU Highlights Symposium

2022 ASCO GU Highlights

In the following videos, faculty from Dana-Farber Cancer Institute review highlights from the 2022 ASCO GU Symposium.